Influence of proinflammatory cytokine gene polymorphism on childhood obesity

European Journal of Medical Research

Volumn 14, Issue SUPPL.4, 2009, Pages 59-62

  Popko, K ^a   Garska E ^a   Pyrzak, B ^a   Telmaszczyk Emmel, A ^a   Wisniewska, A ^a   Majcher, A ^a   Wasik, M ^a   Demkow, U ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

diabetes; gene polymorphism; IL 1; IL 6; inflammatory cytokines; obesity; TNF alpha

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; OBESITY;

ADOLESCENT; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; OBESITY; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955499405     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-14-S4-59     Document Type: Article

References (32)

1. Genetic and environmental correlations among hormone levels and measures of body fat accumulation and topography. Comuzzie AG, Blangero J, Mahaney MC, Haffner SM, Mitchell BD, Stern MP, MacCluer JW, J Clin Endocrinol Metab 1996 81 597 600 10.1210/jc.81.2.597 8636274 (Pubitemid 26055670)
2. Genetic and environmental factors in relative body weight and human adiposity. Maes HH, Neale MC, EaVes L, Behav Genet 1997 27 325 351 10.1023/A:1025635913927 9519560 (Pubitemid 27415169)
3. An adoption study of human obesity. Stunkard AJ, N Engl J Med 1986 314 193 198 10.1056/NEJM198601233140401 3941707 (Pubitemid 16183148)
4. TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup A, Eur J Clin Invest 1992 22 396 402 10.1111/j.1365-2362.1992. tb01480.x 1353022
5. The hetitability of body mass index among an international sample of monozygotic twins reared apart. Allison DB, Int J Obes Relat Metab Disord 1996 20 501 506 8782724 (Pubitemid 26174333)
6. Frequency of distribution of lepton receptor gene polymorphism in obstructive sleep apnea patients. Popko K, Gorska E, Wasik M, Stoklosa T, Plywaczewski R, Winiarska M, Gorecka D, Sliwinski P, Demkow U, J Physiol Pharmacol 2007 58 Suppl 5 551 561 18204169 (Pubitemid 351346705)
7. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrel MA, Am J Physiol Endocrinol Metabol 2001 280 827 847
8. The metabolic effects of tumor necrosis factor and other cytokines. Grunfeld C, Feingold KR, Biotherapy 1991 3 143 158 10.1007/BF02172087 2054255
9. Adipose tissue as an endocrine and paracrine organ. Mohamed-Ali V, Pinkney JH, Coppack SW, Int J Obes 1998 22 1145 1158 10.1038/sj.ijo.0800770 (Pubitemid 28548534)
10. Omental and subcutaneous adipose tissue of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. Fried SK, Bunkin DA, Greengerg AS, J Clin Endocrinol Metabol 1998 83 847 850 10.1210/jc.83.3.847 (Pubitemid 28496456)
11. Expression pattern of tumor necrosis factor in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Hube F, Birgel M, Lee YM, Hauner H, Eur J Clin Invest 1999 29 672 678 10.1046/j.1365-2362.1999.00520.x 10457150 (Pubitemid 29366714)
12. Frequency of distribution of cytokines IL-1, IL-6 and TNF-alfa gene polymorphism in patients with obstructive sleep apnea. Popko K, Gorska E, Potapinska O, Wasik M, Stoklosa T, Plywaczewski R, Winiarska M, Gorecka D, Sliwinski P, Popko M, Szwed T, Demkow U, J Physiol Pharmacol 2008 59 Suppl 6 607 614 19218687
13. The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and an association with systemic-onset juvenile chronic arthritis. Fishman D, Faulds G, Jeffery R, Mohamed Ali V, Yudkin YS, Humphries S, Woo P, J Clin Invest 1998 102 1369 1376 10.1172/JCI2629 9769329 (Pubitemid 28467565)
14. Interleukin-6 deficient mice develop mature-onset obesity. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson J-O, Nature Med 2002 8 75 79 10.1038/nm0102-75 11786910 (Pubitemid 34101732)
15. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Plata-Salaman CR, Nutrition 2000 16 1009 1012 10.1016/S0899-9007(00) 00413-5 11054608
16. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Tsigos C, Papanicolaou DA, Defensor R, Mitsidis CS, Kyrou I, Chrousos GP, Neuroendocrinology 1997 66 54 62 10.1159/000127219 9258919 (Pubitemid 27271992)
17. Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. Fernandes-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W, J Clin Endocrinol Metabol 2001 86 1154 1159 10.1210/jc.86.3.1154 (Pubitemid 32322997)
18. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP, Am J Physiol 1996 271 601 E605 8843757
19. Responses of the sympathetic nervous system and the hypothalamic- pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR, Arthritis Rheum 2000 43 872 880 10.1002/1529-0131(200004)43:4<872::AID-ANR19>3.0. CO;2-T 10765933
20. Sympathetic neurons can produce and respond to interleukin 6. Marz P, Cheng JG, Gadient RA, Patterson PH, Stovan T, Otten U, Rose-John S, Proc Natl Acad Sci 1998 95 3251 3256 10.1073/pnas.95.6.3251 9501249 (Pubitemid 28135888)
21. Endocrinologic and metabolic effects of interleukin-6 in humans. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, Sauerwein HP, Am J Physiol 1995 268 813 E819 7762632
22. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leiber RL, J Clin Endocrinol Metabol 2002 87 2391 2394 10.1210/jc.87.5.2391 (Pubitemid 34521535)
23. Role of cytokines in inducing hyperlipidemia. Feingold KR, Grunfeld C, Diabetes 1992 41 Suppl 2 97 101 1526345
24. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alfa and obesity-induced insulin resistance. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM, Science 1996 271 665 668 10.1126/science.271.5249.665 8571133 (Pubitemid 26052915)
25. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Hotomisligil GS, Murray DL, Choy LN, Spiegelman BM, Proc Natl Acad Sci 1994 91 4854 4858 10.1073/pnas.91.11.4854 8197147 (Pubitemid 24177748)
26. TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup A, Eur J Clin Invest 1992 22 396 402 10.1111/j.1365-2362.1992. tb01480.x 1353022
27. Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes-evidence for polygenicity in men. Danish Study Group of Diabetes in Childhood. Pociot F, Ronningen KS, Bergholdt R, Lorencen T, Johannesen J, Ye K, Autoimmunity 1994 19 169 178 10.3109/08916939408995692 7605869
28. Resting release by human adipose tissue explants in primary culture. Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M, Biochem Biophys Res Commun 2003 300 674 678 10.1016/S0006-291X(02)02864-4 12507502 (Pubitemid 36268889)
29. Dexamethasone inhibits tumor necrosis factor-alpha-induced apoptosis and interleukin-1 beta release in human subcutaneous adipocytes and preadipocytes. Zhang HH, Kumar S, Barnett AH, Eggo MC, J Clin Endocrinol Metabol 2001 86 2817 2825 10.1210/jc.86.6.2817 (Pubitemid 32545745)
30. Recombinant interleukin-1 suppresses lipoprotein lipase activity in 3T3-L1 cells. Beutler BA, Cerami A, J Immunol 1985 135 3969 3971 2999235 (Pubitemid 16250377)
31. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Memon RA, Feingold KR, Moser AH, Fuller J, Grunfeld C, Am J Physiol 1998 274 210 E217 9486149
32. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Bruun JM, Pedersen SB, Kristensen K, Richelsen B, Mol Cell Endocrinol 2002 190 91 99 10.1016/S0303-7207(02)00007-2 11997182 (Pubitemid 34464102)